Sign up to save your podcasts
Or
Share E126: Risk Signals, JAKs, and SELECTIVE-ity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E126: Risk Signals, JAKs, and SELECTIVE-ity
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published
Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091
View all episodes
By Michael Putman
4.9
114114 ratings
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published
Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
504 Listeners
Mayo Clinic Talks
295 Listeners
Rheumnow Podcast
126 Listeners
The Curbsiders Internal Medicine Podcast
3,375 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
520 Listeners
ACR on Air
66 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
5 Listeners
The Curious Clinicians
377 Listeners
Rheumatology For The Royal College
181 Listeners
Febrile
190 Listeners
ACR Journals On Air
20 Listeners
Talking Rheumatology Spotlight
5 Listeners